newsfilter
← Latest News
GlobeNewswire·

Exagen Inc. to Participate in Upcoming Investor Conference

  • Exagen Inc. (NASDAQ: XGN) management will attend the Canaccord Genuity 46th Annual Growth Conference in Boston, MA on August 11, 2026.
  • The company will host a fireside chat at 8:30 am ET during the event.
  • A live & archived webcast of the presentation will be available on Exagen's Investor Relations website at investors.exagen.com.
  • Exagen is a San Diego County-based provider of autoimmune diagnostics focused on improving outcomes for chronic autoimmune conditions.
  • The company's flagship product, AVISE® CTD, aids in the accurate & early diagnosis of lupus, rheumatoid arthritis, & Sjögren's disease.
  • Exagen operates a CLIA-certified & CAP-accredited laboratory specializing in rheumatic disease testing with a suite of AVISE-branded tests.
  • Tina Jacobsen, CFA, serves as the investor relations contact for Exagen at IR@exagen.com.